Adithi Randeni | Transcytosis Mechanisms and Hydrocephalus Pathophysiology | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Adithi Randeni | Transcytosis Mechanisms and Hydrocephalus Pathophysiology | Best Researcher Award

Leeds Teaching Hospitals Trust, United Kingdom

Dr. Randeni A. Adithi H. Randeni is a Foundation Year One doctor at Leeds Teaching Hospital Trust with a dynamic portfolio in clinical research, innovation, and academic leadership. A graduate of the University of Leeds (MBChB), she has gained international exposure through observerships and research collaborations in the UK and USA, including SUNY Upstate. Her scholarly contributions span neurosurgery, cerebrospinal fluid dynamics, and biomedical innovation, with publications in top-tier journals such as IJMS, BJS, and BMC Medical Education. Dr. Randeni has received numerous awards and bursaries and is an active educator and mentor. Her leadership roles in university bodies and national societies reflect her commitment to academic excellence and inclusivity. With a future goal of specializing in neurosurgery, she aims to contribute to translational research and advance surgical practice globally through innovation and collaboration.

Profile

🎓 Education

Dr. Adithi Randeni earned her Bachelor of Medicine and Bachelor of Surgery (MBChB) from the University of Leeds, where she excelled in both academic and research endeavors. Her education was enriched by multiple research projects and electives across the UK and internationally, including SUNY Upstate Medical University in the USA. During her time at Leeds, she engaged deeply with translational research, contributing to projects on hydrocephalus, tissue engineering, neurotrauma, and breast cancer genetics. Her academic training included structured research programs and specialized modules in biomedical innovation, CSF dynamics, and advanced surgical techniques. She also undertook audits, systematic reviews, and service evaluations during clinical placements. Beyond formal education, she participated in national research fellowships and student interest groups that fostered interdisciplinary learning and mentorship. Dr. Randeni’s educational journey reflects a strong integration of clinical knowledge with scientific inquiry, preparing her for a future as a research-driven neurosurgeon and academic leader.

🧪 Experience

Dr. Adithi Randeni currently serves as a Foundation Year One doctor at Leeds Teaching Hospital Trust, where she is engaged in hands-on patient care, audits, and quality improvement projects. She has amassed extensive research experience through clinical, translational, and lab-based projects, including those at SUNY Upstate and the University of Leeds. Her past roles include conducting systematic reviews, performing service evaluations in neurosurgery, and leading national student surveys like SMART. She has presented her findings at both national and international conferences and has co-authored peer-reviewed articles and a book chapter. In addition to clinical duties, she has held leadership roles in student organizations, served as a medical student representative, and organized educational workshops. Her involvement with professional societies and interdisciplinary teams highlights her ability to balance clinical work, academic productivity, and collaborative initiatives, making her a well-rounded early-career professional with a clear trajectory in neurosurgical research and innovation.

🏅 Awards and Honors

Dr. Adithi Randeni has been the recipient of numerous academic awards, conference bursaries, and leadership recognitions during her medical training. Her achievements include international presentation opportunities and publication accolades for research on hydrocephalus, surgical outcomes, and student engagement in research pathways. She was invited to co-author a chapter in Springer’s “Arachnoid Cysts: State-of-the-Art” and has contributed to high-impact journals like the British Journal of Surgery and BMC Medical Education. She has earned research travel grants, elective placement scholarships, and teaching recognitions for organizing peer education workshops. Active in student leadership, she received commendations for her roles within the Medical Student Representative Council and societies such as NANSIG and the National MedTech Foundation. Her selection for the “Best Researcher Award” nomination reflects her growing influence in academic medicine. These honors affirm her commitment to excellence in research, innovation, and medical education at an early stage of her professional journey.

🔬 Research Focus

Dr. Adithi Randeni’s research focus lies at the intersection of neurosurgery, cerebrospinal fluid (CSF) dynamics, and biomedical innovation. She has explored pathological mechanisms such as abnormal transcytosis in hydrocephalus, authored a chapter on the genetics of arachnoid cysts, and is actively investigating CSF composition in hydrocephalus through collaborations with SUNY Upstate. Her research interests also include neurotrauma, surgical outcomes, antimicrobial stewardship, and tissue-engineered cardiovascular grafts. With a strong inclination toward translational research, she integrates clinical insights with lab-based findings to drive innovation. Dr. Randeni also explores medical education, having co-led the SMART study on student engagement in research. Her contributions aim to bridge the gap between bedside care and bench science, with ongoing work assessing surgical site infections and diagnostic accuracy in neurosurgical imaging. She is passionate about leveraging biomedical research and digital tools to enhance patient outcomes and surgical practice, particularly in underserved and complex neurological conditions.

✅ Conclusion

Dr. Adithi Randeni exemplifies the fusion of clinical excellence, research innovation, and educational leadership, positioning her as a promising future leader in neurosurgery and translational science.

Publications

  • Abnormal Transcytosis Mechanisms in the Pathogenesis of Hydrocephalus: A Review

    International Journal of Molecular Sciences
    2025-05-19 | Journal article
    DOI: 10.3390/ijms26104881
    Part ofISSN: 1422-0067
    CONTRIBUTORS: Adithi Randeni; Sydney Colvin; Satish Krishnamurthy

  • Genetics of Arachnoid Cysts

    Arachnoid Cysts
    2023 | Book chapter
    DOI: 10.1007/978-3-031-22701-1_8
    Part ofISBN: 9783031227004
    Part ofISBN: 9783031227011
    CONTRIBUTORS: Adithi Randeni; Sydney Colvin; Satish Krishnamurth

  • Cross-sectional Survey of Medical student perceptions of And desires for Research and Training pathways (SMART): an analysis of prospective cohort study of UK medical students

    BMC Medical Education
    2023-12-15 | Journal article
    DOI: 10.1186/s12909-023-04881-2
    Part of ISSN: 1472-6920
    CONTRIBUTORS: Gokul Parameswaran; Amelia Bowman; Catherine Swales; Setthasorn Zhi Yang Ooi; Shie Wei Chan; Priya Rose Babu; Daniele Ramsay; Sofia Kostoudi; Soham Bandyopadhyay; SMART-NANSIG-InCiSion Collaborative et al.

Timea Claudia Ghitea | Metabolic Syndrome | Women Researcher Award

Published on by Cognitive Scientist Awards

Dr. Timea Claudia Ghitea | Metabolic Syndrome | Women Researcher Award

Universitary Assistant, University of Oradea, Romania

GHITEA TIMEA-CLAUDIA is a Romanian expert in pharmacy and clinical nutrition, with over two decades of professional experience combining pharmaceutical practice, clinical and sports nutrition, and academic teaching. She currently serves as a university assistant at the Faculty of Medicine and Pharmacy in Oradea and leads nutrition initiatives at Echo Laboratories. Her career began in 1999 as a pharmacy assistant, advancing through key leadership roles, including pharmacist director in various pharmacies. Holding dual specialization in pharmacy and biomedical sciences, Dr. Ghitea completed her doctorate in Clinical and Sports Nutrition in 2020. A multilingual professional, she is committed to interdisciplinary collaboration and student mentorship. Her dynamic profile is strengthened by memberships in national and international professional societies. She also contributes actively to administrative roles in academic and pharmaceutical organizations. Dr. Ghitea is a respected voice in the evolving field of clinical nutrition and personalized healthcare in Romania.

Profile

🎓 Education

GHITEA TIMEA-CLAUDIA holds a robust academic portfolio encompassing both pharmaceutical and biomedical disciplines. She earned her Doctorate in Biomedical Sciences with a focus on Clinical and Sports Nutrition in 2020 and completed postgraduate studies in Nutrition and Dietetics in 2017. Her foundational studies include a Master’s degree in Cell Biology (2006), a Pharmacy degree from the Faculty of Medicine and Pharmacy in Oradea (2006), and a Bachelor of Science in Biology-Chemistry (2002). She also holds a diploma as a Pharmacy Assistant from the Vasile Voiculescu Post-High School (1999) and graduated high school from Ady Endre Theoretical High School in 1997. She has continuously enhanced her expertise through specializations such as a residency in Clinical Pharmacy (2009) and various professional training programs. Her academic involvement is complemented by her roles in professional boards and committees, contributing significantly to pharmacy and nutrition education in Romania.

🧪 Experience

GHITEA TIMEA-CLAUDIA brings more than 25 years of hands-on experience in pharmacy, healthcare, and academia. Since 2017, she has served as a university assistant at the Faculty of Medicine and Pharmacy, Oradea, while also leading clinical and sports nutrition services at Echo Laboratories. Previously, she was pharmacist director at Serbien Pharmacy (2012–2017) and MIG3 Pharmacy (2011–2012). Her career began as a pharmacy assistant at Delia Pharmacy (1999–2006), followed by a pharmacist role at Fontana Pharmacy (2006–2011). A proactive mentor and project leader, she supervises internships and facilitates interdisciplinary collaboration to address complex patient cases in nutrition. Her leadership extends to project management and service coordination in clinical nutrition. Her deep understanding of pharmacy and dietetics, combined with strong communication, organizational, and mentoring skills, ensures her consistent contribution to healthcare innovation and medical education. She effectively bridges academic knowledge with clinical application and professional governance.

🏅 Awards and Honors

GHITEA TIMEA-CLAUDIA has earned recognition through key leadership roles and active participation in prominent professional associations. She was appointed President of the Discipline Committee at the College of Pharmacists, Bihor, in 2011, and later served as a member of both the General Assembly and the Discipline Committee. Her involvement spans national and international professional societies, including the American Society for Nutrition (2017), the Romanian Society of Pharmaceutical Sciences (2019), and the Pharmacological Association of Romania (since 2006). She is also a member of the Nutritionists Association of Romania (2022) and the Society of Pharmaceutical History Romania (2019). Her consistent efforts in academic mentorship earned her the role of Internship Mentor, and she was designated Project Manager in 2022. These accolades underscore her leadership, dedication to advancing pharmacy and nutrition sciences, and her commitment to mentoring future professionals. Her honors reflect a sustained contribution to both clinical practice and scholarly engagement.

🔬 Research Focus

Dr. GHITEA TIMEA-CLAUDIA’s research focus lies at the intersection of clinical pharmacy, sports nutrition, and biomedical science. Her work is dedicated to optimizing patient care through evidence-based nutritional strategies and the integration of pharmaceutical knowledge into personalized dietetic plans. Her doctoral studies in Clinical and Sports Nutrition laid the foundation for a research trajectory that includes metabolic optimization, nutritional therapy in chronic diseases, and the role of diet in athletic performance and recovery. She actively collaborates with international colleagues to solve complex clinical nutrition cases and contributes to interdisciplinary projects aimed at enhancing nutritional interventions. As a university assistant and project leader, she mentors students in clinical research methodology, practical case-solving, and the application of nutritional science in medical contexts. Her expertise is instrumental in bridging academic insights with real-world patient outcomes, promoting innovation in clinical nutrition and pharmacy-driven healthcare models.

✅ Conclusion

Dr. Ghitea Timea-Claudia is a dynamic healthcare professional whose career seamlessly bridges pharmaceutical science, clinical nutrition, and academic leadership. Her vast experience, ongoing research, and dedication to student mentorship reflect her holistic and forward-thinking approach to health education and patient care.

Publications

  • Vaccine Adherence: From Vaccine Hesitancy to Actual Vaccination and Reasons for Refusal of Childhood Vaccines in a Group of Postpartum Mothers

    In Vivo
    2025 | Journal article
    DOI: 10.21873/INVIVO.13855
    WOSUID: WOS:001391824800006
    CONTRIBUTORS: Iova, Camelia florina; Daina, Lucia georgeta; Ilea, Codrin dan nicolae; Domnariu, Horatiu Paul; Ghitea, Timea claudia; Daina, Madalina Diana Daina

  • The Impact of Thrombophilia on Maternal and Neonatal Outcomes: A Multisystem Analysis of Clinical, Hematological, and Metabolic Parameters

    Journal of Clinical Medicine
    2025-05-23 | Journal article
    DOI: 10.3390/jcm14113665
    CONTRIBUTORS: Viorela-Romina Murvai; Radu Galiș; Cristina-Maria Macrea; Anca-Florina Tărău-Copos; Marius Daniel Goman; Timea Claudia Ghitea; Anca Huniadi

  • Stomatognathic Dysfunction and Neuropsychological Imbalance: Associations with Salivary Cortisol, EMG Activity, and Emotional Distress

    Dentistry Journal
    2025-05-22 | Journal article
    DOI: 10.3390/dj13060230
    CONTRIBUTORS: Ioana Scrobota; Liliana Sachelarie; Timea Claudia Ghitea; Georgiana Ioana Potra Cicalau; Roxana Alexandra Cristea; Pelea Diana; Petra Saitos; Alexandra Vlad; Loredana Liliana Hurju

  • Correlation Between Vitamin D Deficiency (25(OH)D3) and the Severity of Purulent Oropharyngeal Infections

    Journal of Clinical Medicine
    2025-04-01 | Journal article
    DOI: 10.3390/jcm14072410
    CONTRIBUTORS: Florian Ciprian Venter; Timea Claudia Ghitea; Adrian Nicolae Venter; Amin-Florin El-kharoubi; Mousa El-kharoubi; Evelin Claudia Ghitea; Marc Cristian Ghitea; Amina Vente

  • Psychological Distress and Quality of Life in Patients with Colon Cancer: Predictors, Moderating Effects, and Longitudinal Impact

    Healthcare
    2025-03-27 | Journal article
    DOI: 10.3390/healthcare13070753
    CONTRIBUTORS: Lavinia Alina Rat; Timea Claudia Ghitea; Adrian Marius Maghiar

Yingna Le | Research on the Mechanism of Action of Active Ingredients in Traditional Chinese Medicine | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Yingna Le | Research on the Mechanism of Action of Active Ingredients in Traditional Chinese Medicine | Best Researcher Award

PhD Candidate| Nanchang Medical College, china

Dr. Yingna Le is a Lecturer in Pharmacy at Nanchang Medical College’s School of Pharmacy, where she specializes in pharmacognosy and the authentication of Chinese medicinal materials. With a strong foundation in Chinese Materia Medica from Yunnan and Jiangxi Universities of Traditional Chinese Medicine, she combines traditional knowledge with modern scientific research. Dr. Le actively investigates the molecular mechanisms behind active ingredients in Traditional Chinese Medicine (TCM), contributing to national and provincial research projects. Her work includes the study of hawthorn leaf flavonoids and kidney stone treatments through the lens of network pharmacology and gut-liver axis analysis. She has published in core Chinese and international journals, developed flipped classroom models, and innovated WeChat-based educational tools. A member of several professional societies, she is committed to advancing TCM education and research. Her interdisciplinary approach integrates experimental design, pharmacognosy, and data analysis to enrich teaching and contribute to the scientific community.

Profile

🎓 Education

Dr. Yingna Le holds both Bachelor’s and Master’s degrees in Chinese Materia Medica. She earned her B.S. from Yunnan University of Traditional Chinese Medicine in 2007, where she developed a strong understanding of traditional pharmacognosy and the foundational principles of Chinese medicine. She then pursued her M.S. from Jiangxi University of Traditional Chinese Medicine (2008–2011), deepening her expertise in medicinal material authentication and TCM pharmacology. Her postgraduate studies provided her with skills in microscopic identification, phytochemical analysis, and TCM theory, setting the stage for her research and teaching career. This rigorous academic background enabled her to bridge the gap between traditional practices and contemporary scientific methods. Her educational journey laid the groundwork for her future roles in academia and research, where she continues to explore the integration of modern pharmacological techniques with ancient herbal wisdom. Dr. Le’s academic path demonstrates her dedication to excellence and innovation in the field of TCM.

🧪 Experience

Dr. Yingna Le currently serves as a Lecturer in the School of Pharmacy at Nanchang Medical College (2021–present), where she teaches Pharmacognosy and the Authentication of Chinese Medicinal Materials. Prior to this, she was a Teaching Assistant at the Jiangxi University of TCM Science and Technology College (2018–2021), where she began integrating innovative teaching strategies into traditional Chinese medicine education. Her academic career is marked by a dedication to improving teaching quality through flipped classrooms and the application of digital platforms like WeChat for student engagement and evaluation. In addition to teaching, Dr. Le has played pivotal roles in research, particularly as Principal Investigator and Co-Investigator on national and provincial research grants. She has completed five interdisciplinary projects between 2020 and 2022 and actively contributes to academic publications. Her blend of instructional innovation and research acumen makes her a respected figure in both educational and scientific circles in TCM.

🏅 Awards and Honors

Dr. Yingna Le has earned recognition through competitive research funding and influential academic appointments. She is the Principal Investigator of a Jiangxi Provincial Education Department grant for studying Lygodium japonicum’s mechanisms against kidney stones, and a Co-Investigator on a prestigious National Natural Science Foundation of China (NSFC) grant examining hawthorn leaf flavonoids in cardiovascular treatment. While specific award titles are not listed, her success in securing these high-level grants reflects her scientific credibility and innovation. Additionally, her involvement in five interdisciplinary education reform and material science projects (2020–2022) with substantial budgets highlights her leadership and collaborative spirit. Dr. Le also holds committee roles in key professional societies, including the TCM Processing Committee of the Jiangxi Pharmaceutical Association and the Digital Healthcare & Simulation Medicine Society of Jiangxi Province. These roles further affirm her status as a trusted contributor to the advancement of pharmacy education and research in Traditional Chinese Medicine.

🔬 Research Focus

Dr. Yingna Le’s research centers on uncovering the mechanisms of action of active ingredients in Traditional Chinese Medicine using modern pharmacological approaches. Her work focuses on compounds such as hawthorn leaf flavonoids and their effects on cardiovascular health, particularly unstable plaques, through the LXR-α mediated modulation of iron-lipid metabolism in the gut-liver axis. She also investigates the therapeutic potential of Lygodium japonicum in kidney stone treatment via network pharmacology. Dr. Le employs a range of methodologies including phytochemical analysis, molecular mechanism studies, and pharmacognostic techniques. Her research approach integrates traditional herbal knowledge with systems biology to bridge classical TCM theory with modern biomedical science. She has a strong interest in interdisciplinary collaboration and has led or contributed to numerous research projects across pharmacology, education reform, and material science. Her contributions aim to validate and modernize the application of traditional remedies in contemporary clinical settings, making her work both culturally relevant and scientifically impactful.

✅ Conclusion

Dr. Yingna Le blends traditional Chinese medical expertise with modern research to advance pharmacognosy and medicinal authentication. Through dedicated teaching, impactful research, and innovative education methods, she contributes significantly to TCM modernization.

Publications

Alihossein saberi | Male infertility | Outstanding Scientist Award

Published on by Cognitive Scientist Awards

Dr. Alihossein saberi | male infertility | Outstanding Scientist Award

professor| Ahwaz Jundishapour University of  Medical Sciences, Iran

Dr. Alihossein Saberi is an accomplished molecular geneticist and Associate Professor at Ahvaz Jundishapur University of Medical Sciences. With a career spanning over three decades, he has held several academic and administrative positions, including Head of the Department of Medical Genetics. He earned his PhD in Molecular Medicine from Kyoto University, Japan, following a master’s in Radiation Biology from Tarbiat Modarres University, Iran. Dr. Saberi has taught and mentored extensively in molecular biology, genetics, and radiation biology. He has authored numerous research articles and textbooks, contributing significantly to the field of molecular genetics, particularly in cancer genomics, male infertility, and genetic disorders. He remains deeply involved in collaborative international research. Dr. Saberi is known for integrating teaching, administration, and impactful research to advance medical genetics education and practice in Iran and beyond.

Profile

🎓 Education

Dr. Saberi earned his PhD in Molecular Medicine from the Graduate School of Medicine at Kyoto University, Japan, between 2004 and 2007. Prior to this, he underwent a research traineeship at the same institution from 2003 to 2004. He completed his Master of Science in Radiation Biology in 1992 at Tarbiat Modarres University, Tehran, Iran, where he gained strong foundational knowledge in biomedical sciences. His education trajectory reflects a continuous focus on molecular and cellular biology, particularly genetic mechanisms underlying human health and disease. His exposure to international research environments has significantly shaped his academic and professional outlook, equipping him with advanced techniques in gene expression, molecular diagnostics, and cancer genomics. These academic qualifications have been central to his role in establishing and leading educational and research initiatives in medical genetics in Iran, enhancing both curriculum development and translational research in the domain of human genetics.

🧪 Experience

Dr. Saberi began his academic career in 1992 as a lecturer at Ahvaz Jundishapur University of Medical Sciences, advancing to Assistant Professor (2007–2013), Associate Professor (since 2013), and Head of the Department of Medical Genetics (since 2014). He also served as Deputy of Educational Affairs (1998–1999) and Dean of the Paramedical Faculty (1999–2003), showcasing his administrative leadership. Over the years, he has taught various core subjects such as Molecular Biology, Medical Genetics, and Radiation Biology. His teaching spans over 30 years and is supported by a strong research portfolio and international collaborations. His leadership has led to the development of molecular genetics curricula and enhanced the university’s role in medical genetics research and diagnostics. His blend of academic, research, and administrative roles reflects a holistic contribution to the medical education and healthcare system in Iran, making him a key figure in advancing genetics education and clinical research in the region.

🏅 Awards and Honors

Dr. Alihossein Saberi’s professional excellence is recognized through his appointment as Head of the Department of Medical Genetics and his pivotal role in curriculum reform and academic leadership at Ahvaz Jundishapur University of Medical Sciences. Although specific awards are not listed, his career progression—from lecturer to associate professor and departmental head—underscores recognition of his academic contributions. His participation in international collaborations and co-authorship of high-impact publications in renowned journals such as Genetics in Medicine, Clinical Genitourinary Cancer, and International Journal of Biological Macromolecules reflects international recognition and scientific credibility. Authoring textbooks in Persian further demonstrates his commitment to knowledge dissemination in the native language. His contributions to both education and research continue to position him as a respected expert in the Iranian academic community and an influential collaborator on global genetic research projects, often cited for his work in oncology, neurogenetics, and reproductive genetics.

🔬 Research Focus

Dr. Saberi’s research focuses on molecular genetics with special emphasis on cancer biology, reproductive genetics, and genetic basis of neurodevelopmental disorders. He explores the regulatory role of microRNAs, gene polymorphisms, and novel genetic markers in disease susceptibility and progression. Recent studies include investigations on microRNA-32 in prostate cancer, FSHB polymorphisms in male infertility, and co-delivery of gene therapies in hepatocellular carcinoma. His participation in multi-institutional genomic projects has led to groundbreaking findings in INPP4A-related neurodevelopmental disorders and biallelic mutations in ZBTB11 and MED27 genes. Using bioinformatics and translational genetics approaches, he aims to bridge the gap between molecular insights and clinical applications. He also explores the genetic basis of recurrent implantation failure and precision medicine in oncology. His collaborative work with international consortia highlights his commitment to global research excellence in human genetics, positioning him as a significant contributor to personalized medicine and molecular diagnostics.

✅ Conclusion

Dr. Alihossein Saberi is a leading molecular geneticist whose work spans academia, research, and administration, with a legacy of advancing genetic medicine education and research in Iran through decades of dedicated service, innovation, and collaboration.

Publications

  • Gold nanoparticles in combination with megavoltage radiation energy increased radiosensitization and apoptosis in colon cancer HT-29 cells

    International Journal of Radiation Biology
    2017 | Journal article
    DOI: 10.1080/09553002.2017.1242816

    EID:

    2-s2.0-84994131604

    CONTRIBUTORS: Saberi, A.; Shahbazi-Gahrouei, D.; Abbasian, M.; Fesharaki, M.; Baharlouei, A.; Arab-Bafrani, Z.

  • Impact of prolonged fraction delivery time modelling stereotactic body radiation therapy with high dose hypofractionation on the killing of cultured ACHN renal cell carcinoma cell line

    Journal of Biomedical Physics and Engineering
    2017 | Journal article
    DOI: 10.22086/jbpe.v7i3%20Sep.582

    EID:

    2-s2.0-85029830802

    CONTRIBUTORS: Khorramizadeh, M.; Saberi, A.; Tahmasebi-birgani, M.; Shokrani, P.; Amouhedari, A.

  • The first report of a 290-bp deletion in β-globin gene in the south of Iran

    Iranian Biomedical Journal
    2017 | Journal article
    DOI: 10.18869/acadpub.ibj.21.2.126

    EID:

    2-s2.0-85012202227

    CONTRIBUTORS: Hamid, M.; Nejad, L.D.; Shariati, G.; Galehdari, H.; Saberi, A.; Mohammadi-Anaei, M.

Elijah Stommel | Toxicology | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Elijah Stommel | Toxicology | Best Researcher Award

Dr. Elijah W. Stommel is a distinguished neurologist born in Hamilton, Bermuda 🌊, currently serving as Professor of Neurology at the Geisel School of Medicine at Dartmouth 🧠, renowned for his clinical expertise, pioneering ALS research, and dedication to patient-centered care 💡; his prolific academic journey, consulting roles, and leadership in rare disease research reflect decades of unwavering service to neurology 🏥, academia 📚, and public health advocacy 🧬.

Profile

Education 🎓

Dr. Stommel holds an M.D. (1987) and a Ph.D. in Physiology (1984) from Boston University School of Medicine 🎓; he earned a B.A. with High Honors in Music from Bowdoin College 🎵 (1977), pursued advanced coursework at MIT 🏛️, and honed his research skills as a Research Assistant at the Marine Biological Laboratory in Woods Hole 🔬 — blending physiology, neurology, and music to form a truly interdisciplinary academic foundation 📘.

Experience 👨‍🏫

With over three decades in clinical neurology 🧠, Dr. Stommel progressed from Chief Resident at Dartmouth-Hitchcock (1990-91) to Professor of Neurology (2013–present) 👨‍🏫; he has served as Staff Neurologist at Dartmouth-Hitchcock Clinic since 1991 🏥, held multiple consultant roles across Vermont and New Hampshire 🗺️, and co-directs the Electromyography Lab ⚡, establishing himself as a trusted educator, clinician, and research mentor in both academic and hospital environments 🌟.

Awards & Recognitions 🏅

Dr. Stommel’s commitment to humanism and excellence in neurology earned him a nomination for the prestigious Tow Humanism in Medicine Award 🏆 (2011); he is a Fellow of the American Academy of Neurology 🎖️ and holds long-standing certifications in Electrodiagnostic Medicine and Neurology 🧠, complemented by leadership roles on numerous committees advancing research ethics, clinical trials, and medical education 📋💡.

Research Interests 🔬

Dr. Stommel’s research revolves around neurodegenerative diseases, especially ALS 🧬, exploring environmental toxins 🌿, nanotechnology 🧪, and biomarkers 🔍 to advance diagnostics and therapeutics; as an active reviewer and editor for journals like Nature Nanotechnology, Frontiers in Neurology, and Molecular Neurobiology 🧠, he continually shapes scientific discourse while his collaborative work with global ALS consortia helps identify novel causal pathways and treatment avenues 🌍💡.

Publications

Yuanyuan Li | Movement Disorder | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Yuanyuan Li | Movement Disorder | Best Researcher Award

🧠 Dr. Yuanyuan Li is a dedicated neurologist and researcher specializing in neurodegenerative diseases, particularly Parkinson’s disease and REM sleep behavior disorder. She obtained her Ph.D. in Neurology from Shanghai Jiao Tong University School of Medicine and has been actively involved in cutting-edge research at Ruijin Hospital’s Department of Neurology. As a project leader, she has explored the role of α-synuclein in dopaminergic neurons, investigating its transport pathways and impact on cell viability. Dr. Li has authored multiple high-impact publications in renowned journals such as Neurology and J Neuroinflammation. Her work has contributed significantly to understanding the early biomarkers of neurodegenerative disorders. She has received prestigious awards, including the National Scholarship for Doctoral Students and the Outstanding Graduate Award from Shanghai Jiao Tong University. With numerous conference presentations and accolades, Dr. Li continues to drive forward advancements in neurodegenerative disease research. ✨📚

Profile

Education 🎓

🎓 Dr. Yuanyuan Li completed her Ph.D. in Neurology at Shanghai Jiao Tong University School of Medicine, where she focused on neurodegenerative diseases, particularly Parkinson’s disease and REM sleep behavior disorder. Her doctoral research emphasized the role of α-synuclein in dopaminergic neurons, uncovering its impact on neurodegeneration. Throughout her academic journey, Dr. Li consistently demonstrated excellence, earning the First-Class Academic Scholarship and the Meritorious Student Award. She was recognized as an Outstanding Graduate and received the prestigious National Scholarship for Doctoral Students. Beyond coursework, she actively engaged in translational research, bridging laboratory findings with clinical applications. Her education has provided a strong foundation in neurobiology, molecular neuroscience, and clinical neurology. With a passion for uncovering early biomarkers of neurodegeneration, Dr. Li’s educational background has shaped her into a leading researcher in the field. 📖🧬

Experience 👨‍🏫

Dr. Yuanyuan Li has extensive research experience at Ruijin Hospital’s Department of Neurology, affiliated with Shanghai Jiao Tong University School of Medicine. As a principal investigator, she led the Shanghai Jiao Tong University Doctoral Innovation Fund project, studying α-synuclein’s transport mechanisms in dopaminergic neurons and its effects on cell viability. Her expertise spans biomarker discovery, neuroinflammation, and disease progression in neurodegenerative disorders. She has collaborated on numerous high-impact studies published in Neurology, J Neuroinflammation, and NPJ Parkinson’s Disease. Dr. Li has also presented her findings at major conferences, including the National Neurology Conference and the Oriental Neurology Conference. Her experience in both basic and clinical research allows her to bridge the gap between laboratory discoveries and patient applications, advancing diagnostic and therapeutic strategies for Parkinson’s disease and related disorders. 🏥🧠

Awards & Recognitions 🏅

Dr. Yuanyuan Li has received numerous prestigious awards for her contributions to neurology and neuroscience research. She was awarded the National Scholarship for Doctoral Students, recognizing her academic excellence and groundbreaking research. She also received the Outstanding Graduate Award and the Meritorious Student Award from Shanghai Jiao Tong University. Her outstanding academic performance earned her the First-Class Academic Scholarship, demonstrating her dedication to advancing neurological research. Dr. Li has been recognized for her contributions at major conferences, winning the “Excellent Paper Presentation” award at the Oriental Neurology Conference. Additionally, she secured First Prize for Poster Presentation at the “Bo Ji Yi Yuan” Academic Forum. Her accolades reflect her commitment to advancing our understanding of neurodegenerative diseases, particularly Parkinson’s disease. These honors highlight her as a rising star in the field of neurology. 🏅📜

Research Interests 🔬

🧪 Dr. Yuanyuan Li’s research focuses on neurodegenerative diseases, with an emphasis on Parkinson’s disease, REM sleep behavior disorder (RBD), and α-synuclein pathology. Her work explores the molecular mechanisms driving these disorders, particularly the role of α-synuclein in dopaminergic neurons, its transport pathways, and its impact on cell viability. She has also investigated immune biomarkers, neuroinflammation, and genetic variants associated with Parkinson’s progression. Dr. Li’s studies have contributed to identifying predictive markers for early-stage neurodegenerative diseases, aiding in early diagnosis and potential therapeutic interventions. Through her publications in top journals like Neurology, J Neuroinflammation, and NPJ Parkinson’s Disease, she has advanced knowledge in the field. Her work integrates clinical and experimental neuroscience, bridging gaps between laboratory findings and real-world applications. Dr. Li’s research continues to shape the understanding of neurodegenerative disorders and their early detection. 🧬🔍

 

4Publications 

  • Gene Polymorphisms of Parkinson’s Disease Risk Locus and Idiopathic REM Sleep Behavior Disorder

    Biomedicines
    2025-03-24 | Journal article
    DOI: 10.3390/biomedicines13040788
    CONTRIBUTORS: Min Zhong; Yang Jiao; Aonan Zhao; Mengyue Niu; Jinjun Ran; Jun Liu; Yuanyuan Li

  • Understanding Causal Relationships Between Imaging-Derived Phenotypes and Parkinson’s Disease: A Mendelian Randomization and Observational Study

    Biomedicines
    2025-03-18 | Journal article
    DOI: 10.3390/biomedicines13030747
    CONTRIBUTORS: Yichi Zhang; Min Zhong; Zhao Yang; Xiaojin Wang; Zhongxun Dong; Liche Zhou; Qianyi Yin; Bingshun Wang; Jun Liu; Yuanyuan Li et al.

  • Understanding Causal Relationships between Imaging-Derived Phenotypes and Parkinson’s Disease: A Mendelian Randomization and Observational Study

    2025-02-05 | Preprint
    DOI: 10.20944/preprints202502.0350.v1
    CONTRIBUTORS: Yichi Zhang; Min Zhong; Zhao Yang; Xiaojin Wang; Zhongxun Dong; Liche Zhou; Qianyi Yin; Bingshun Wang; Jun Liu; Yuanyuan Li et al.

  • Network disruption based on multi-modal EEG-MRI in α-synucleinopathies

    Frontiers in Neurology
    2024 | Journal article
    DOI: 10.3389/FNEUR.2024.1442851
    WOSUID: WOS:001304283700001
    CONTRIBUTORS: Wang, Chunyi; Hu, Jiajia; Li, Puyu; Zhang, Ming; Zhou, Liche; Luo, Ningdi; Zhu, Xue; Yin, Qianyi; Zhong, Min; Zhou, Xinyi et al.

PİNAR ERKEKOGLU | Neurotoxicology | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. PİNAR ERKEKOGLU | Neurotoxicology | Best Researcher Award

Prof. Dr. Pınar Erkekoğlu is a distinguished academician and toxicologist at Hacettepe University, serving as Head of the Department of Pharmaceutical Toxicology and Department of Vaccine Technology. She holds a PhD in toxicology (2009) and became a European Registered Toxicologist (ERT) in 2014. She conducted research at Joseph Fourier University, CEA/INAC/LAN, and completed her postdoctoral studies at MIT (2011-2013). With over 200 scientific publications, 10 edited books, and 15 book chapters, her work spans toxicology, neurotoxicology, and vaccinology. Her h-index is 34, with 107 SCI-indexed papers and numerous collaborations.

Profile

Education 🎓

Prof. Erkekoğlu earned her Pharmacy degree from Hacettepe University and a PhD in toxicology (2009). She gained international research experience at Joseph Fourier University and CEA/INAC/LAN during her doctorate. In 2011-2013, she pursued postdoctoral research at MIT, specializing in toxicology and environmental sciences. Recognized for her expertise, she became a European Registered Toxicologist (ERT) in 2014.

Experience 👨‍🏫

Prof. Erkekoğlu has extensive experience in toxicology, environmental sciences, and vaccinology. She is the Head of Pharmaceutical Toxicology and Vaccine Technology at Hacettepe University. She has worked at MIT, Joseph Fourier University, and CEA/INAC/LAN. With 49 research projects, 4 industry consultancies, and 12 collaborations, she has contributed significantly to toxicological sciences.

Awards & Recognitions 🏅

Prof. Erkekoğlu has received numerous awards, including Best Researcher and Women Researcher Awards. She is recognized internationally for her contributions to toxicology, neurotoxicology, and vaccine technology. She has served as an editor for scientific books, peer-reviewed journals, and major toxicology conferences.

Research Interests 🔬

Her research encompasses neurotoxicology, endocrine disruption, environmental toxicology, and vaccinology. She has published 107 SCI-indexed papers and 161 documents in Scopus across pharmacology, medicine, and environmental sciences. Her work explores the toxic effects of chemicals on human health and vaccine development.

Publications 

  • Prepubertal phthalate exposure can cause histopathological alterations, DNA methylation and histone acetylation changes in rat brain

    Toxicology and Industrial Health
    2025-03 | Journal article
    DOI: 10.1177/07482337251315212
    CONTRIBUTORS: Seyda Koc; Ekin Erdogmus; Ozlem Bozdemir; Deniz Ozkan-Vardar; Unzile Yaman; Pınar
    Erkekoglu; Naciye Dilara Zeybek; Belma Kocer-Gumusel

  • The ameliorative potential of metformin against aluminum‐induced neurotoxicity: Insights from in vitro studies

    Journal of Applied Toxicology
    2025-02 | Journal article
    DOI: 10.1002/jat.4695
    CONTRIBUTORS: Sonia Sanajou; Anil Yirün; Göksun Demirel; Pinar Erkekoğlu; Gönül Şahin; Terken Baydar

  • Unveiling connections: bisphenol A and vitamin D dynamics in breast milk among healthy lactating mothers

    International Journal of Environmental Health Research
    2024-10-10 | Journal article
    DOI: 10.1080/09603123.2024.2412118
    CONTRIBUTORS: Esra Cinkilli Aktağ; Sıddika Songül Yalçin; Anıl Yіrün; Aylin Balci Özyurt; Pınar Erkekoğlu

  • Bisphenol derivatives in cord blood and association between thyroid hormones and potential exposure sources

    International Journal of Environmental Health Research
    2024-08-02 | Journal article
    DOI: 10.1080/09603123.2023.2286016
    CONTRIBUTORS: Merve Buke Sahin; Murat Cagan; Anıl Yirun; Aylin Balcı Ozyurt; Selinay Basak Erdemli Kose; Irem Iyigun; Melda Celik; Ozgur Ozyuncu; Pınar Erkekoglu; Cavit Isik Yavuz

  • Comparative in silico and in vitro evaluation of possible toxic effects of bisphenol derivatives in HepG2 cells

    Toxicology Research
    2024-07-01 | Journal article
    DOI: 10.1093/toxres/tfae127
    CONTRIBUTORS: Aylin Balci-Ozyurt; Anıl Yirun; Deniz Arca Cakır; İbrahim Ozcelik; Merve Bacanli; Gizem Ozkemahli; Suna Sabuncuoglu; Nursen Basaran; Pınar Erkekogl

 

Aynur Müdüroğlu Kırmızıbekmez | Neurodevelopmental Disorders | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof Dr. Aynur Müdüroğlu Kırmızıbekmez | Neurodevelopmental Disorders | Best Researcher Award

Asst. Prof. Aynur Müdüroğlu Kırmızıbekmez is a neuroscientist at İstanbul Nişantaşı University, specializing in neurodegenerative diseases, neuroprotection, and the gut-brain axis. She completed her Ph.D. in Neuroscience at Istanbul University in 2013 and has been a faculty member since 2014. Her research spans Alzheimer’s, autism, and Parkinson’s disease, focusing on stem cell therapies and functional foods for cognitive enhancement. She has led TÜSEB-approved projects and holds patents on bioactive functional foods. Aynur teaches Neurology, Cognitive Neurophysiology, and Industrial Biotechnology. She actively contributes to cutting-edge innovations, particularly in prebiotic-microbiota interactions.

Profile

Education 🎓

Aynur Müdüroğlu Kırmızıbekmez earned her Ph.D. in Neuroscience from Istanbul University in 2013. Her academic journey emphasized neurobiology, neurodegenerative disease mechanisms, and innovative therapeutic strategies. Her doctoral research focused on neuroprotective compounds in Alzheimer’s disease. Before her Ph.D., she pursued studies in molecular biology and biotechnology, refining her expertise in cellular neuroscience. Throughout her education, she collaborated on interdisciplinary projects, integrating neurophysiology with pharmacological advancements. Her postdoctoral research extended into translational neuroscience, bridging laboratory findings with clinical applications. Aynur’s academic foundation laid the groundwork for her extensive research on cognitive function, stem cell therapy, and the gut-brain axis.

Experience 👨‍🏫

With over a decade of experience, Aynur Müdüroğlu Kırmızıbekmez has been an Assistant Professor at İstanbul Nişantaşı University since 2014. She has led multiple national and international neuroscience projects, including TÜSEB-approved research on Parkinson’s and Alzheimer’s diseases. Aynur has played a pivotal role in developing functional foods aimed at cognitive enhancement and has secured patents for novel bioactive compounds. She actively collaborates with industry and academia, integrating neuroscience with biotechnology. Her teaching portfolio includes Neurology, Cognitive Neurophysiology, and Industrial Biotechnology. She has also mentored numerous graduate students in neuropharmacology and neurodegenerative research.

Research Interests 🔬

Aynur Müdüroğlu Kırmızıbekmez’s research focuses on neurodegenerative diseases, neuroprotection, and the gut-brain axis. She explores innovative therapies for Alzheimer’s, Parkinson’s, and autism, with a strong emphasis on stem cell applications. Her work investigates the neuroprotective potential of bioactive compounds and functional foods, aiming to enhance cognitive function. She has pioneered research on the microbiota-brain relationship, particularly the role of prebiotics in neurodegeneration. Aynur’s projects also include SNP-based qPCR diagnostic tools for Alzheimer’s risk assessment. Through interdisciplinary collaborations, she integrates neuroscience with biotechnology, advancing the understanding of cognitive disorders and potential therapeutic interventions.

Awards & Recognitions 🏅

Aynur Müdüroğlu Kırmızıbekmez has received multiple awards for her contributions to neuroscience, including national research grants and innovation awards for her work on functional foods for neuroprotection. She was honored by TÜSEB for her groundbreaking research in stem cell therapy for Parkinson’s disease. Her patented functional chocolate enriched with bioactive compounds received recognition for its cognitive benefits. Aynur has also been awarded project grants from TÜBİTAK for her research on neurodegeneration. She has been invited as a keynote speaker at international neuroscience conferences and has been recognized for her contributions to cognitive science.

Publications 📚

  • Attila Altunel, Aynur Muduroglu-Kirmizibekmez, Alparslan Onder, Ozlem Altunel, Ali
    Sever, Ihsan Kara, Efficacy of ACTH therapy in children with Landau-Kleffner Syndrome
    and Autism Spectrum Disorder: A retrospective analysis, Epilepsy & Behavior,Vol
    165,2025,110308, https://doi.org/10.1016/j.yebeh.2025.11030
  • Muduroglu-Kirmizibekmez A, Cati C, Onder A, Aydin S, Kara I. Investigation of the acute
    impact of rosemary consumption on brain activity in healthy volunteers. Nutr
    Neurosci. 2024 Jul 6:1-12. doi: 10.1080/1028415X.2024.2370729. Epub ahead of print.
    PMID: 38970803.
  • Biliz Y, Hasdemir B, Başpınar Küçük H, Zaim M, Şentürk AM, Müdüroğlu Kırmızıbekmez
    A, Kara İ. Novel N-Acyl Hydrazone Compounds as Promising Anticancer Agents:
    Synthesis and Molecular Docking Studies. ACS Omega. 2023 May 20;8(22):20073-
    20084. doi: 10.1021/acsomega.3c02361. PMID: 37305237; PMCID: PMC10249086.
  • Aydin S, Erözden AA, Tavşanlı N, Müdüroğlu A, Çalışkan M, Kara İ. Anthocyanin
    Addition to Kefir: Metagenomic Analysis of Microbial Community Structure. Curr
    Microbiol. 2022 Sep 20;79(11):327. doi: 10.1007/s00284-022-03017-x. PMID:
    36125585
  • Altunel Atilla, Müdüroğlu Kirmizibekmez Aynur, Altunel Emine Özlem (2022).
    Hypsarrhythmia Paroxysm Intensities that Initiate and Render Physical & Mental
    Retardation Irreversible in West Syndrome. International Journal of Neuroscience,
    DOI: 10.1080/00207454.2022.2078208 (Publication No: 7685958)

Carmela Conte | Neurodegenerative diseases | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof Dr. Carmela Conte | Neurodegenerative diseases | Best Researcher Award

 

Profile

Education

Carmela Conte obtained her Master’s degree in Biological Sciences from the University of Perugia on November 3, 1994. She then pursued a Ph.D. in Medical Embryology through a joint program between the Universities of Perugia and Ferrara, completing it between December 30, 1996, and January 19, 2000. Following this, she specialized in Chemistry and Food Technology at the University of Perugia, earning her specialization between November 1, 2000, and November 1, 2002. Most recently, on September 29, 2023, she received National Habilitation as an Associate Professor in Biochemistry. She currently serves as an Aggregate Professor in her field.

Work experience

Since September 7, 2007, Carmela Conte has been serving as an Aggregate Professor in Biochemistry at the University of Perugia, where she teaches courses in General and Systematic Biochemistry, Medical Applied Biochemistry, and Molecular Biology. In addition to her teaching responsibilities, she participated in a Teaching and Training Mobility Program at VUMC Medical University of Amsterdam from June 24 to July 5, 2019, where she worked on a research project investigating the role of Toll-like receptors in Parkinson’s disease. She has been a member of the European Society for Neurochemistry since 2007 and, since March 17, 2022, has also been affiliated with the International Parkinson and Movement Disorder Society.

Research Activity

Carmela Conte’s research focuses on neurodegenerative diseases, with particular emphasis on animal models, signal transduction, molecular biology, and cell biology. Her specific research topics include the role of Toll-like receptors in Parkinson’s disease, neuroinflammation, synucleinopathies, oxidative stress, and Parkinson’s disease. Since September 7, 2007, she has been actively involved in editorial work, serving as a Reviewer Editor for Frontiers in Neuroscience (Neurodegeneration section) and as an ad hoc reviewer for several journals, including Amino Acids, The Cerebellum, Free Radical Research, Biomolecules, PLOS One, Experimental Gerontology, Molecules, Cells, Neurochemical Research, Neuroscience, Pharmacological Reports, International Journal of Molecular Sciences, Viruses, and the Journal of Biotechnology. Additionally, she has been a Guest Editor for Molecules and Cells, overseeing special issues and topic collections on neurodegenerative diseases. She has presented her research at numerous scientific meetings and conferences, including the 2009 Meeting of the European Society for Neurochemistry in Leipzig, the 2019 European Biotechnology Congress in Valencia, the 2021 European Biotechnology Congress in Sofia, the 2022 National Meeting of the Sphingolipid Club, and the 2023 Meeting of Parkinson’s Disease and Movement Disorders, where she discussed findings related to Toll-like receptor 4, alpha-synuclein accumulation, and sphingomyelinase activity in Parkinson’s disease models.

Publication

Suleyman Yildizdal | Craniosynostosis | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Suleyman Yildizdal | Craniosynostosis | Best Researcher Award

 

 

Profile

Education

He completed his education at Org. Kenan Evren School from 2000 to 2008, followed by Gaziantep Anadolu High School from 2008 to 2012. He then pursued his medical training at Hacettepe University Faculty of Medicine from 2012 to 2018. After earning his medical degree, he continued his specialization in Plastic, Reconstructive, and Aesthetic Surgery as a resident at Hacettepe University Faculty of Medicine from November 2018 to February 2024. In April 2024, he joined Ankara Research and Training Hospital, where he continues to work in the Department of Plastic, Reconstructive, and Aesthetic Surgery.

 

Work experience

He has participated in various courses and workshops to enhance his expertise in plastic, reconstructive, and aesthetic surgery. He attended the Resident Ethics Course at Hacettepe University’s Department of History of Medicine and Medical Ethics on January 10-11, 2019. He also completed the 5th Basic Residency School organized by the Turkish Society of Plastic, Reconstructive, and Aesthetic Surgery in Bolu, Turkey, from January 22-25, 2020. Further advancing his skills, he took part in the 15th Advanced Residency School in Antalya, Turkey, from April 20-24, 2023. Additionally, he attended the 1st Cadaver Course of Craniofacial Anomaly and Maxillofacial Surgery at Hacettepe University on September 3-4, 2022, and the 1st Cadaver Course of Orthognathic Surgery at Koc University Hospital in Istanbul, Turkey, on September 7-8, 2022.

In addition to his clinical and surgical training, he has contributed to academic literature by co-authoring book chapters. He co-wrote Age-Related Changes in Trunk Aesthetics in Beauty, Aging, and Anti-Aging (1st ed., Elsevier, 2022) alongside G. G. Üstün and S. Yıldızdal. He also contributed to Dudak ve Damak Yarıkları Hacettepe Ekip Yaklaşım, co-authoring “Apert and Crouzon Syndrome” with İbrahim Vargel.

Awards

He has achieved remarkable academic success, securing 16th place in the National Examination for Specialty in Medicine among over 18,000 participants. Additionally, he ranked 571st in the National Student Selection and Placement Examination out of more than 2 million candidates.

He has actively participated in national meetings within his field, contributing to discussions and advancements in plastic, reconstructive, and aesthetic surgery. He attended the 41st National Turkish Plastic Reconstructive and Aesthetic Surgery Meeting in Samsun, Turkey, from October 26-30, 2019. He also participated in the National Turkish Plastic Reconstructive and Aesthetic Surgery Eastern Mediterranean Meeting on Cleft Lip and Palate, held in Gaziantep, Turkey, from February 7-9, 2020. Furthermore, he attended the 43rd National Turkish Plastic Reconstructive and Aesthetic Surgery Meeting in Antalya, Turkey, from November 10-14, 2021.

 

Publication